COVID-19 drug trial pulled before it started
Disease control
Terminated
This study was designed to test whether the drug itolizumab could help hospitalized COVID-19 patients recover faster. It planned to enroll adults with severe pneumonia and low oxygen levels. However, the trial was withdrawn before any participants were enrolled, so no results are…
Phase: PHASE3 • Sponsor: Biocon Limited • Aim: Disease control
Last updated May 17, 2026 06:22 UTC